Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03818061
Title Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck (ATHENA)
Acronym ATHENA
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Leon Berard
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Centre Léon Bérard Lyon 69373 France Details
Centre Antoine Lacassagne Nice 06189 France Details
Institut Curie Paris 75005 France Details
Centre Henri Becquerel Rouen 76038 France Details
Clinique Mutualiste de l'Estuaire Saint-Nazaire 44606 France Details
Centre Paul Strauss Strasbourg 67065 France Details
Institut Claudius Regaud Toulouse 31059 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field